Articles by William Looney

The Sum of All His Parts: Career Reflections of Europe's Chief Drug Regulator

Dec 1, 2010
By: William Looney

Outgoing EMA Director Thomas Lonngren discusses a decade at the helm of Europe's top regulatory office

Is Euroland Following the US Disclosure Lead?

Dec 1, 2010
By: William Looney

Cegedim survey documents whether European industry is ready for the challenge of new compliance and disclosure risks on promotional spend

Pharma's Identity, From I to T

Nov 1, 2010
By: William Looney

The FDA process itself is looking more like the unsavory 'sausage factory' associated with drafting partisan legislation

Japan: The Real Emerging Market?

Nov 1, 2010
By: William Looney

With all the money and momentum focused on medicines in emerging markets, it may be time to take a closer look at business opportunities in this more familiar neighbor to the East

Nobel Laureate Elie Wiesel Exclusive Interview

Ethical behavior can be a bridge-builder in an era where Big Pharma needs to find new partners. Is it up to the challenge?
Oct 1, 2010
By: William Looney

Ethical behavior can be a bridge-builder in an era where Big Pharma needs to find new partners. Is it up to the challenge?

Community: The Business of Life

Oct 1, 2010
By: William Looney

Adam Smith's theory of the uncompromising market may set the tone for today's capitalism, but we forget that his first work,"The Theory of Moral Sentiments," made 'bettering the human condition' the basis from which all productive commerce flows.

The Coming Second Act

Sep 1, 2010
By: William Looney

Reinvention takes more than a pithy redraft of the strategy plan or mission statement; money, a change in business culture, and the mindset of thousands of employees is required too